ArticleBreast cancer (Tokyo, Japan)2026
Fear of diagnosis as a barrier to the screening and diagnosis of breast cancer.
Article in Breast cancer (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBreast cancer diagnosis primarily occurs through mammography and biopsy. Treatment options span from surgery to chemotherapy, contingent on the cancer stage. While preventative measures such as lifestyle adjustments like weight management and reduced alcohol intake can reduce cases of breast cancer, challenges persist in accessing timely screening and treatment, especially in low- and middle-income areas of the country.
methodsThis survey engaged 59 US mothers 16 years and older with breast cancer. Administered to ensure distinct responses, it included questions covering family history, personal risk factors, menstrual cycles, pregnancies, barriers to mammograms, and strategies for enhancing healthcare support and awareness.
resultsParticipant ages were distributed as follows: <18 (1.14%), 18-30 (38.64%), 31-40 (23.86%), 41-50 (21.59%),>50 (14.77%). A family history of ovarian or breast cancer was reported by 41 participants (69%). Identified risk factors included family history (83%), smoking (61%), alcohol consumption (44%), obesity (39%), early menarche (31%), and late menopause (22%). Awareness of recommended breast cancer screening was high, with 48 participants aware (81%). A majority (80%) believed earlier mammograms were warranted. DISCUSSION: Participants underscored the significant genetic component in ovarian or breast cancer and outlined barriers to mammograms such as cost, insurance gaps, and limited awareness of financial aid. They recommended improving healthcare provider awareness, support, and access to mammogram screenings. Enhanced education on breast cancer risks and procedures was also advocated, emphasizing the need for robust support programs to assist patients in navigating their diagnosis effectively.
conclusionThe study reveals that in this survey of mothers with breast cancer, women delay mammogram screenings due to financial concerns and fear of diagnosis. Implementing widespread medical aid initiatives can alleviate the stigma of having breast cancer, ultimately increasing screening efforts and reducing the progression and severity of breast cancer in women.
Indexed as
Identifiers
41944955What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.